September 26, 2017 8:00 AM ET

Healthcare Equipment and Supplies

Company Overview of RenalGuard Solutions, Inc.

Company Overview

RenalGuard Solutions, Inc. manufactures medical devices for cardiac and vascular markets. It offers RenalGuard that removes contrast dyes that may be toxic to the kidney in at-risk patients undergoing certain cardiac and vascular imaging procedures. The company also provides RenalGuard Therapy to reduce the toxic effects that contrast media can have on the kidneys, which may lead to a reduction in the incidence of contrast-induced nephropathy in at-risk patients; and RenalGuard System that comprises a console and a RenalGuard single use set for infusion and urine collection. It sells its products through a network of distributors in the United States and internationally. The company was foun...

459 Fortune Boulevard

Milford, MA 01757

United States

Founded in 2014



Key Executives for RenalGuard Solutions, Inc.

Chief Executive Officer
Chief Business & Financial Officer and Managing Director
Age: 40
Vice President of Operations
Age: 56
Chief Technology Officer
Compensation as of Fiscal Year 2017.

RenalGuard Solutions, Inc. Key Developments

RenalGuard Solutions, Inc. Appoints Jim Dillon as Chief Executive Officer

RenalGuard Solutions, Inc. announced the appointment of Jim Dillon, former St. Jude Medical and Abiomed commercial executive, as Chief Executive Officer. Jim Dillon joined St. Jude Medical in 2011 and has held a series of increasingly responsible corporate strategic and sales leadership positions. Within these roles, he drove market development and new technology adoption, executed capital/consumable sales strategies and built high performance elite commercial teams focused on the sales and marketing of complex and innovative medical devices. Prior to joining St. Jude, he also held senior executive sales and marketing positions with such companies as Abiomed, TherOx and InfraReDx, where he was intimately involved with global clinical development and commercial distribution.

RenalGuard Solutions, Inc. Appoints J. Alex Martin as Chairman

RenalGuard Solutions, Inc. announced the appointment of J. Alex Martin as Chairman of the RenalGuard Board of Directors. Ethan Benovitz, remains as Vice-Chairman of the RenalGuard Board. As the President, CEO and Director of Coherex Medical, Mr. Martin led the company to a successful exit with Biosense Webster, in November 2015. Prior to Coherex, he was the President and CEO of WorldHeart Corporation. Previously, Mr. Martin has held senior leadership roles with Edwards Lifesciences, Cordis Corporation, Cambridge Heart and C.R. Bard.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Private Placement
March 16, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RenalGuard Solutions, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at